ID   KUCaP13
AC   CVCL_C0UV
SY   Kyoto University Cancer Prostate 13
DR   cancercelllines; CVCL_C0UV
DR   Wikidata; Q112929970
RX   PubMed=33960594;
CC   Population: Japanese.
CC   Characteristics: Established via a mouse xenograft.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1915; CHD1; Zygosity=Homozygous (PubMed=33960594).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.His61Arg (c.182A>G); ClinVar=VCV000189402; Zygosity=Unspecified (PubMed=33960594).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg209Lysfs*6 (c.626_627delGA); ClinVar=VCV000372539; Zygosity=Heterozygous (PubMed=33960594).
CC   Omics: Deep exome analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: Metastatic; Penis; UBERON=UBERON_0000989.
ST   Source(s): PubMed=33960594
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 16,18
ST   D21S11: 32.2,33.2
ST   D3S1358: 14,15
ST   D5S818: 10,11
ST   D7S820: 10
ST   D8S1179: 13,14,15
ST   FGA: 22
ST   Penta D: 10,11
ST   Penta E: 17
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C158913; Metastatic prostate neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
RX   PubMed=33960594; DOI=10.1111/cas.14935; PMCID=PMC8253279;
RA   Okasho K., Mizuno K., Fukui T., Lin Y.-Y., Kamiyama Y., Sunada T.,
RA   Li X., Kimura H., Sumiyoshi T., Goto T., Kobayashi T., Lin D.,
RA   Wang Y.-Z., Collins C.C., Inoue T., Ogawa O., Akamatsu S.;
RT   "Establishment and characterization of a novel treatment-related
RT   neuroendocrine prostate cancer cell line KUCaP13.";
RL   Cancer Sci. 112:2781-2791(2021).
//